Crescent Capital BDC (NASDAQ:CCAP) Price Target Lowered to $15.00 at LADENBURG THALM/SH SH

Crescent Capital BDC (NASDAQ:CCAP) had its target price trimmed by LADENBURG THALM/SH SH from $16.00 to $15.00 in a research note published on Friday morning,Benzinga reports. The firm currently has a buy rating on the stock.

Other equities analysts have also recently issued reports about the company. Wells Fargo & Company cut their price objective on Crescent Capital BDC from $13.00 to $12.00 and set an “equal weight” rating for the company in a report on Friday. Keefe, Bruyette & Woods cut their price objective on Crescent Capital BDC from $15.50 to $15.00 and set an “outperform” rating for the company in a report on Thursday, April 16th. Oppenheimer cut Crescent Capital BDC from an “outperform” rating to a “market perform” rating and dropped their target price for the company from $19.00 to $16.00 in a report on Friday. Zacks Research upgraded Crescent Capital BDC from a “strong sell” rating to a “hold” rating in a report on Tuesday, February 10th. Finally, B. Riley Financial reaffirmed a “neutral” rating on shares of Crescent Capital BDC in a research report on Friday. Two investment analysts have rated the stock with a Buy rating and four have given a Hold rating to the stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and a consensus target price of $14.30.

Crescent Capital BDC Price Performance

CCAP opened at $11.13 on Friday. The stock has a 50-day moving average price of $12.93 and a 200-day moving average price of $13.76. Crescent Capital BDC has a 12-month low of $11.03 and a 12-month high of $16.03. The company has a current ratio of 1.53, a quick ratio of 1.22 and a debt-to-equity ratio of 1.35. The stock has a market capitalization of $410.14 million, a P/E ratio of 27.15 and a beta of 0.59.

Crescent Capital BDC (NASDAQ:CCAP) last posted its quarterly earnings data on Wednesday, May 13th. The company reported $0.42 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.41 by $0.01. Crescent Capital BDC had a return on equity of 9.34% and a net margin of 9.26%.The firm had revenue of ($6.84) million during the quarter, compared to analysts’ expectations of $39.58 million. Equities analysts predict that Crescent Capital BDC will post 1.63 earnings per share for the current fiscal year.

Crescent Capital BDC Announces Dividend

The firm also recently declared a special dividend, which will be paid on Tuesday, December 15th. Shareholders of record on Monday, November 30th will be given a dividend of $0.03 per share. The ex-dividend date of this dividend is Monday, November 30th. This represents a yield of 107.0%. Crescent Capital BDC’s dividend payout ratio is presently 409.76%.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently bought and sold shares of the business. Invesco Ltd. raised its position in shares of Crescent Capital BDC by 1,504.9% in the 4th quarter. Invesco Ltd. now owns 659,696 shares of the company’s stock worth $9,269,000 after acquiring an additional 618,590 shares in the last quarter. North Ground Capital raised its position in shares of Crescent Capital BDC by 99.8% in the 4th quarter. North Ground Capital now owns 835,312 shares of the company’s stock worth $11,736,000 after acquiring an additional 417,312 shares in the last quarter. Focus Partners Wealth bought a new position in shares of Crescent Capital BDC in the 4th quarter worth approximately $5,476,000. Closed End Fund Advisors Inc. bought a new position in shares of Crescent Capital BDC in the 4th quarter worth approximately $3,166,000. Finally, Alpine Global Management LLC bought a new position in shares of Crescent Capital BDC in the 3rd quarter worth approximately $3,137,000. Institutional investors own 49.46% of the company’s stock.

Key Crescent Capital BDC News

Here are the key news stories impacting Crescent Capital BDC this week:

• Positive Sentiment: The company beat Q1 2026 EPS estimates, reporting $0.42 per share versus the $0.41 consensus, which shows earnings held up slightly better than expected. Crescent Capital BDC (CCAP) Tops Q1 Earnings Estimates
• Positive Sentiment: Management cut fees, lowering the base management fee to 1.00% from 1.25% and the incentive fee to 15.0% from 17.5%, a move that should support future earnings and better align with shareholders. Crescent Capital BDC, Inc. Reports First Quarter 2026 Earnings Results; Declares a Second Quarter Base Dividend of $0.34 Per Share and Series of Special Dividends
• Positive Sentiment: CCAP declared a regular quarterly dividend of $0.34 per share and three special dividends of $0.03 each, reinforcing its income appeal for investors. Crescent Capital BDC, Inc. Reports First Quarter 2026 Earnings Results; Declares a Second Quarter Base Dividend of $0.34 Per Share and Series of Special Dividends
• Neutral Sentiment: Several analysts reiterated broadly constructive but mixed views: Ladenburg trimmed its price target to $15 from $16 while keeping a buy rating, and Oppenheimer reaffirmed a market perform rating. Benzinga
• Negative Sentiment: Q1 performance was weighed down by a net loss of $0.42 per share and a decline in NAV per share to $18.27 from $19.10, signaling weaker underlying portfolio marks. Crescent Capital BDC, Inc. Reports First Quarter 2026 Earnings Results; Declares a Second Quarter Base Dividend of $0.34 Per Share and Series of Special Dividends
• Negative Sentiment: Investment income fell year over year and the quarter included larger realized and unrealized losses, which may be making investors cautious about near-term earnings quality. Crescent Capital BDC, Inc. Reports First Quarter 2026 Earnings Results; Declares a Second Quarter Base Dividend of $0.34 Per Share and Series of Special Dividends

About Crescent Capital BDC

Crescent Capital BDC, Inc is a closed-end, externally managed business development company that provides flexible financing solutions to middle market companies in the United States. Trading on the Nasdaq under the ticker CCAP, the firm offers investors exposure to a diversified portfolio of debt and equity instruments, targeting businesses with attractive risk-adjusted return profiles. Its primary objective is to generate current income through interest payments and potential capital appreciation via selective equity co-investments.

The company’s investment strategy emphasizes senior secured loans, unsecured second-lien loans, mezzanine debt, as well as preferred and common equity co-investments.